Toripalimab Combined With Chidamide for the Treatment of Relapsed/Refractory Peripheral T-Cell Lymphoma

NCT06492629 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

43

Enrollment

OTHER

Sponsor class

Conditions

PTCL

Interventions

DRUG: Toripalimab
DRUG: chidamide

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences